| Ms Jennifer K Rezabek, MPT | |
|
134 Chesterfield Valley Drive, Chesterfield, MO 63005-1161 | |
| (636) 812-0094 | |
| (636) 812-0152 |
| Full Name | Ms Jennifer K Rezabek |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 15 Years |
| Location | 134 Chesterfield Valley Drive, Chesterfield, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093045940 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2009037275 (Missouri) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Athletico Ltd | 4789602681 | 1957 |
News Archive
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Neurological Disorders and Stroke (NINDS) are launching a five-year, $7.5 million natural history study of Duchenne muscular dystrophy (Duchenne), a degenerative genetically-linked neuromuscular disease. The study aims to validate non-invasive approaches to monitor the progression and treatment of Duchenne, and holds potential to facilitate the development of promising new therapies for people with the disease.
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has closed a $13 million extension of their Series B financing.
In an effort to limit possible prescription narcotic misuse and dependence among its members, Blue Cross Blue Shield of Massachusetts (BCBSMA) announced today that it is instituting enhanced safety measures on how it will cover the use of powerful pain killers.
In an International Wound Journal study of 4,818 older patients undergoing elective orthopedic surgeries, five risk factors were linked with an increased risk of developing surgical site infections, including diabetes, morbid obesity, tobacco smoking, prolonged surgical duration, and lower serum albumin levels prior to surgery.
BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that a study published in the Proceedings of the National Academy of Sciences demonstrated that hyperthermia can be a powerful tool to inhibit the ability of cancer cells to repair the DNA damage caused by radiation or chemotherapy.
› Verified 9 days ago
| Provider Name | Athletico Ltd |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1114449857 PECOS PAC ID: 4789602681 Enrollment ID: O20171211002357 |
News Archive
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Neurological Disorders and Stroke (NINDS) are launching a five-year, $7.5 million natural history study of Duchenne muscular dystrophy (Duchenne), a degenerative genetically-linked neuromuscular disease. The study aims to validate non-invasive approaches to monitor the progression and treatment of Duchenne, and holds potential to facilitate the development of promising new therapies for people with the disease.
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has closed a $13 million extension of their Series B financing.
In an effort to limit possible prescription narcotic misuse and dependence among its members, Blue Cross Blue Shield of Massachusetts (BCBSMA) announced today that it is instituting enhanced safety measures on how it will cover the use of powerful pain killers.
In an International Wound Journal study of 4,818 older patients undergoing elective orthopedic surgeries, five risk factors were linked with an increased risk of developing surgical site infections, including diabetes, morbid obesity, tobacco smoking, prolonged surgical duration, and lower serum albumin levels prior to surgery.
BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that a study published in the Proceedings of the National Academy of Sciences demonstrated that hyperthermia can be a powerful tool to inhibit the ability of cancer cells to repair the DNA damage caused by radiation or chemotherapy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jennifer K Rezabek, MPT 15 Apex Dr, Suite 105, Highland, IL 62249-1282 Ph: (618) 441-0482 | Ms Jennifer K Rezabek, MPT 134 Chesterfield Valley Drive, Chesterfield, MO 63005-1161 Ph: (636) 812-0094 |
News Archive
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute of Neurological Disorders and Stroke (NINDS) are launching a five-year, $7.5 million natural history study of Duchenne muscular dystrophy (Duchenne), a degenerative genetically-linked neuromuscular disease. The study aims to validate non-invasive approaches to monitor the progression and treatment of Duchenne, and holds potential to facilitate the development of promising new therapies for people with the disease.
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has closed a $13 million extension of their Series B financing.
In an effort to limit possible prescription narcotic misuse and dependence among its members, Blue Cross Blue Shield of Massachusetts (BCBSMA) announced today that it is instituting enhanced safety measures on how it will cover the use of powerful pain killers.
In an International Wound Journal study of 4,818 older patients undergoing elective orthopedic surgeries, five risk factors were linked with an increased risk of developing surgical site infections, including diabetes, morbid obesity, tobacco smoking, prolonged surgical duration, and lower serum albumin levels prior to surgery.
BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that a study published in the Proceedings of the National Academy of Sciences demonstrated that hyperthermia can be a powerful tool to inhibit the ability of cancer cells to repair the DNA damage caused by radiation or chemotherapy.
› Verified 9 days ago
Midwest Physical Rehab, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 14821 Clayton Rd, Chesterfield, MO 63017 Phone: 636-227-0559 Fax: 636-227-0232 | |
Advanced Training And Rehab Physical Therapist Medicare: Medicare Enrolled Practice Location: 14450 S Outer 40 Rd, Chesterfield, MO 63017 Phone: 314-434-6060 | |
Mrs. Jacqueline Ann Mcmanus, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1025 Chesterfield Pointe Pkwy, Chesterfield, MO 63017 Phone: 636-489-4116 | |
Elizabeth Beckner, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1585 Woodlake Dr, Suite 214, Chesterfield, MO 63017 Phone: 314-205-8858 Fax: 314-205-2113 | |
Athletico Ltd Physical Therapist Medicare: Medicare Enrolled Practice Location: 14825 N Outer 40 Rd Ste 300, Chesterfield, MO 63017 Phone: 636-812-1211 Fax: 636-812-0159 | |
Manual Therapy Specialists, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 17300 N Outer 40, Suite 205, Chesterfield, MO 63005 Phone: 636-728-1777 Fax: 636-728-1793 | |
Laura Ann Edmundson, MPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 17300 N Outer 40 Rd, Suite 202, Chesterfield, MO 63005 Phone: 636-728-1777 Fax: 636-728-1793 |